<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.2d1 20170631//EN" "JATS-journalpublishing1.dtd">
<article xlink="http://www.w3.org/1999/xlink" dtd-version="1.0" article-type="healthcare" lang="en"><front><journal-meta><journal-id journal-id-type="publisher">IJCRR</journal-id><journal-id journal-id-type="nlm-ta">I Journ Cur Res Re</journal-id><journal-title-group><journal-title>International Journal of Current Research and Review</journal-title><abbrev-journal-title abbrev-type="pubmed">I Journ Cur Res Re</abbrev-journal-title></journal-title-group><issn pub-type="ppub">2231-2196</issn><issn pub-type="opub">0975-5241</issn><publisher><publisher-name>Radiance Research Academy</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">688</article-id><article-id pub-id-type="doi"/><article-id pub-id-type="doi-url"/><article-categories><subj-group subj-group-type="heading"><subject>Healthcare</subject></subj-group></article-categories><title-group><article-title>BIOCHEMICAL CHANGES HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENTS BEFORE AND AFTER ANTIRETROVIRAL THERAPY&#13;
</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>P.</surname><given-names>Usha kiran</given-names></name></contrib><contrib contrib-type="author"><name><surname>P.</surname><given-names>Komala</given-names></name></contrib></contrib-group><pub-date pub-type="ppub"><day>20</day><month>12</month><year>2014</year></pub-date><volume>)</volume><issue/><fpage>43</fpage><lpage>47</lpage><permissions><copyright-statement>This article is copyright of Popeye Publishing, 2009</copyright-statement><copyright-year>2009</copyright-year><license license-type="open-access" href="http://creativecommons.org/licenses/by/4.0/"><license-p>This is an open-access article distributed under the terms of the Creative Commons Attribution (CC BY 4.0) Licence. You may share and adapt the material, but must give appropriate credit to the source, provide a link to the licence, and indicate if changes were made.</license-p></license></permissions><abstract><p>Objectives: The aim of present study was to evaluate the levels of liver enzymes and lipid abnormalities in patients receiving antiretroviral therapy compared to controls. Lactic acidosis was one of the known complications of ART which is the major cause of discontinuation of treatment. Methods: Siemens Dimension Expand Plus fully automated random access analyzer was used for analyzing different parameters. Results: Mean plasma levels of ALT and AST were more in HIV infectedpatients than control group. These parameters were further increased in HIV infected patients after ART. Mean plasma levels of cholesterol and HDL are lower than control group in HIV infected patients before treatment. Cholesterol levels increased after HAART whereas HDL level decreased. Mean plasma levels of triglycerides, LDL and lactic acid are high in HIV infected patients than control and they are further increased after ART. Conclusion: Serum liver enzymes are significantly increased after ART and may be used as prognostic marker of lactic acidosis. This study helps in diagnosing lactic acidosis which can be treated successfully so as to render patients to adhere to treatment to decrease mortality.&#13;
</p></abstract><kwd-group><kwd>HIV</kwd><kwd> ART</kwd><kwd> Lactic acid</kwd><kwd> Liver enzymes</kwd><kwd> Lipid profile</kwd></kwd-group></article-meta></front></article>
